A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction
Status:
Not yet recruiting
Trial end date:
2024-01-15
Target enrollment:
Participant gender:
Summary
The primary objective is to explore if HRS8179 could improve midline shift at 72 hours (or at
time of decompressive craniectomy or comfort measures only, if earlier) in participants with
large hemispheric infarction. The secondary objective is to explore if HRS8179 could improve
acute neurologic status, functional outcomes, treatment requirements and safety.